Hudock Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $580K | Buy |
2,303
+7
| +0.3% | +$1.51K | 0.07% | 117 |
|
|
2026
Q1 | $499K | Buy |
2,296
+62
| +3% | +$13.8K | 0.07% | 114 |
|
|
2025
Q4 | $511K | Buy |
2,234
+6
| +0.3% | +$1.37K | 0.08% | 113 |
|
|
2025
Q3 | $516K | Buy |
2,228
+4
| +0.2% | +$815 | 0.08% | 111 |
|
|
2025
Q2 | $413K | Sell |
2,224
-12
| -0.5% | -$2.23K | 0.07% | 123 |
|
|
2025
Q1 | $468K | Buy |
2,236
+2
| +0.1% | +$389 | 0.08% | 98 |
|
|
2024
Q4 | $397K | Buy |
2,234
+5
| +0.2% | +$919 | 0.07% | 113 |
|
|
2024
Q3 | $440K | Buy |
2,229
+4
| +0.2% | +$747 | 0.08% | 105 |
|
|
2024
Q2 | $382K | Buy |
2,225
+5
| +0.2% | +$828 | 0.07% | 111 |
|
|
2024
Q1 | $404K | Sell |
2,220
-581
| -21% | -$100K | 0.09% | 96 |
|
|
2023
Q4 | $434K | Buy |
2,801
+68
| +2% | +$9.91K | 0.09% | 89 |
|
|
2023
Q3 | $408K | Buy |
2,733
+279
| +11% | +$41K | 0.1% | 84 |
|
|
2023
Q2 | $331K | Buy |
2,454
+406
| +20% | +$59.5K | 0.08% | 101 |
|
|
2023
Q1 | $327K | Buy |
2,048
+4
| +0.2% | +$612 | 0.08% | 103 |
|
|
2022
Q4 | $330K | Buy |
2,044
+431
| +27% | +$66.1K | 0.11% | 100 |
|
|
2022
Q3 | $216K | Buy |
1,613
+7
| +0.4% | +$1K | 0.07% | 128 |
|
|
2022
Q2 | $245K | Sell |
1,606
-5
| -0.3% | -$764 | 0.08% | 116 |
|
|
2022
Q1 | $261K | Sell |
1,611
-378
| -19% | -$54.9K | 0.07% | 126 |
|
|
2021
Q4 | $269K | Sell |
1,989
-523
| -21% | -$61.8K | 0.08% | 128 |
|
|
2021
Q3 | $270K | Buy |
2,512
+12
| +0.5% | +$1.37K | 0.08% | 125 |
|
|
2021
Q2 | $281K | Buy |
2,500
+111
| +5% | +$12.5K | 0.08% | 124 |
|
|
2021
Q1 | $258K | Buy |
2,389
+12
| +0.5% | +$1.28K | 0.08% | 118 |
|
|
2020
Q4 | $254K | Buy |
2,377
+490
| +26% | +$47.1K | 0.08% | 118 |
|
|
2020
Q3 | $165K | Buy |
1,887
+801
| +74% | +$75.4K | 0.06% | 136 |
|
|
2020
Q2 | $106K | Buy |
1,086
+22
| +2% | +$1.94K | 0.04% | 168 |
|
|
2020
Q1 | $81K | Sell |
1,064
-329
| -24% | -$28K | 0.03% | 167 |
|
|
2019
Q4 | $124K | Buy |
1,393
+14
| +1% | +$1.16K | 0.04% | 157 |
|
|
2019
Q3 | $104K | Buy |
1,379
+657
| +91% | +$45K | 0.04% | 161 |
|
|
2019
Q2 | $52K | Sell |
722
-84
| -10% | -$6.6K | 0.02% | 235 |
|
|
2019
Q1 | $65K | Sell |
806
-65
| -7% | -$5.32K | 0.02% | 209 |
|
|
2018
Q4 | $79K | Buy |
871
+5
| +0.6% | +$440 | 0.03% | 177 |
|
|
2018
Q3 | $81K | Buy |
866
+3
| +0.3% | +$284 | 0.03% | 187 |
|
|
2018
Q2 | $79K | Buy |
863
+5
| +0.6% | +$488 | 0.03% | 182 |
|
|
2018
Q1 | $81K | Buy |
858
+5
| +0.6% | +$549 | 0.03% | 180 |
|
|
2017
Q4 | $82K | Buy |
853
+5
| +0.6% | +$471 | 0.04% | 183 |
|
|
2017
Q3 | $75K | Sell |
848
-694
| -45% | -$52.8K | 0.04% | 185 |
|
|
2017
Q2 | $111K | Buy |
1,542
+806
| +110% | +$54.2K | 0.06% | 130 |
|
|
2017
Q1 | $47K | Buy |
736
+56
| +8% | +$3.52K | 0.03% | 228 |
|
|
2016
Q4 | $42K | Buy |
680
+5
| +0.7% | +$305 | 0.02% | 233 |
|
|
2016
Q3 | $42K | Buy |
675
+5
| +0.7% | +$324 | 0.02% | 243 |
|
|
2016
Q2 | $41K | Buy |
670
+68
| +11% | +$4.14K | 0.02% | 251 |
|
|
2016
Q1 | $34K | Buy |
602
+38
| +7% | +$2.12K | 0.02% | 277 |
|
|
2015
Q4 | $33K | Buy |
564
+3
| +0.5% | +$173 | 0.01% | 253 |
|
|
2015
Q3 | $30K | Buy |
561
+1
| +0.2% | +$65 | 0.01% | 266 |
|
|
2015
Q2 | $37K | Buy |
560
+2
| +0.4% | +$131 | 0.02% | 246 |
|
|
2015
Q1 | $33K | Hold |
558
| – | – | 0.01% | 268 |
|
|
2014
Q4 | $37K | Hold |
558
| – | – | 0.02% | 240 |
|
|
2014
Q3 | $32K | Hold |
558
| – | – | 0.02% | 259 |
|
|
2014
Q2 | $31K | Sell |
558
-200
| -26% | -$10.5K | 0.04% | 274 |
|
|
2014
Q1 | $39K | Buy |
758
+200
| +36% | +$10.1K | 0.03% | 232 |
|
|
2013
Q4 | $29K | Hold |
558
| – | – | 0.02% | 263 |
|
|
2013
Q3 | $25K | Hold |
558
| – | – | 0.02% | 234 |
|
|
2013
Q2 | $23K | Buy |
+558
| New | +$24.4K | 0.03% | 238 |
|
Other funds holding ABBV
Hudock Inc's ABBV Position: Q2 2026 in Review
Hudock Inc increased its AbbVie (ABBV) stake by 0.3% in Q2 2026, buying an estimated $1.51K and bringing the position to 2,303 shares worth $580K. The position accounts for 0.07% of the portfolio, ranked #117.
Hudock Inc first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Hudock Inc held 2,303 shares of AbbVie worth $580K as of Q2 2026.
- Hudock Inc bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
- AbbVie made up 0.07% of Hudock Inc's portfolio in Q2 2026, its #117 holding.
- Hudock Inc first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Hudock Inc's 13F filing for Q2 2026, filed 31 Jul 2026.